Esokem IT 40mg/150mg Capsule SR is a combination pharmaceutical formulation containing Esomeprazole 40mg and Itopride 150mg, designed for the management of gastrointestinal disorders. Esomeprazole, a proton pump inhibitor, acts by selectively inhibiting the H+/K+ ATPase enzyme system at the secretory surface of gastric parietal cells, thereby suppressing gastric acid secretion and promoting ulcer healing. It is effectively used in conditions such as gastroesophageal reflux disease (GERD), erosive esophagitis, and Zollinger-Ellison syndrome. Itopride, a prokinetic agent, enhances gastrointestinal motility by antagonizing dopamine D2 receptors and inhibiting acetylcholinesterase activity, facilitating gastric emptying and improving symptoms of functional dyspepsia, including bloating, nausea, and early satiety. The sustained-release (SR) formulation ensures prolonged therapeutic effects, improving patient compliance and symptom control. Esokem IT is indicated for patients requiring both acid suppression and enhanced gastrointestinal motility, particularly in cases where delayed gastric emptying exacerbates acid-related symptoms. It should be administered under medical supervision, with caution in patients with hypersensitivity to either component, and is contraindicated in those with mechanical obstruction of the gastrointestinal tract. Common adverse effects may include headache, diarrhea, and abdominal discomfort. Regular monitoring is advised to assess therapeutic efficacy and detect potential side effects.